Singapore Institute of Advanced Medicine Holdings Ltd. (SGX:9G2)

Singapore flag Singapore · Delayed Price · Currency is SGD
0.0340
-0.0010 (-2.86%)
At close: Oct 8, 2025
-2.86%
Market Cap40.36M
Revenue (ttm)15.71M
Net Income (ttm)-26.16M
Shares Out1.06B
EPS (ttm)-0.02
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume50,100
Average Volume422,270
Open0.0350
Previous Close0.0350
Day's Range0.0340 - 0.0350
52-Week Range0.0260 - 0.0850
Betan/a
RSI57.46
Earnings DateOct 29, 2025

About SGXC:9G2

Singapore Institute of Advanced Medicine Holdings Ltd., an investment holding company, provides medical diagnostics and treatments, and radiation therapy and medical oncology services in Singapore. The company offers medical diagnostics and treatments, including cancer-related diagnostics and theranostics treatments, general diagnostics and health screening, and aesthetic services; and radiation therapy and medical oncology services comprise proton beam therapy, photon radiation therapy, and medical oncology services. It provides clinic and ima... [Read more]

Industry Medical Laboratories
Founded 2011
Country Singapore
Stock Exchange Singapore Exchange - Catalist
Ticker Symbol 9G2
Full Company Profile

Financial Performance

In 2025, SGXC:9G2's revenue was 15.71 million, a decrease of -5.63% compared to the previous year's 16.65 million. Losses were -26.16 million, -30.14% less than in 2024.

Financial Statements

News

There is no news available yet.